CD8A and neoplasm: Indeed, OV treated tumours have demonstrated an increase in tumour infiltrating CD8+ T cells and the systemic presence of tumour antigen specific CD8+ T cells, in addition to a decrease in immunosuppressive MDSCs and Tregs within the TME [27,28,29,31,33,39,40,42,44,45,46,48].